Alessa Therapeutics Appoints Dr. Peter Carroll and Dr. Neal Shore to Lead Clinical Advisory Board

Alessa Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Cam Gallagher, President and CEO, and Pamela Munster, MD, Founder and Chief Scientific Advisor, will present a company overview and clinical update

Alessa Therapeutics Announces Closing $15M Seed Financing

Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery technology for the early

Startups Are Making the Global Gig Economy Bigger. But Can They Make It Better? (SSIR)

Founders and investors should think about more than scale as they roll out gig economy platforms to the developing world. Doing so won’t just help workers; it will give platforms a better chance at...

F.L.Putnam Adds 3 Firms Totaling $1.25B in Managed Assets

The acquisition of the three East Coast-based firms will push F.L.Putnam’s assets under advisement above $10 billion, and its AUM will reach about $7.9 billion.